Fatty amides group - Public comments summary
Official title: Fatty amides group public comments summary
Comments on the draft screening assessment report for the fatty amides group to be addressed as part of the chemicals management plan were submitted during the 60-day public comment period.
A summary of comments and responses is provided below, organized by topic:
1. Consultation & stakeholder engagement
| Summarized comment | Summarized response |
|---|---|
| Assistance is being offered if additional information is required for the 3 substances (CAS RNs 120-40-1, 142-78-9, and 68603-42-9) to be assessed within the alkanolamines group. | The Government of Canada is committed to consulting extensively with all affected stakeholders as part of the risk assessment process. |
2. Increasing transparency
| Summarized comment | Summarized response |
|---|---|
| To facilitate the tracking of substances, it would be helpful to cross-reference substances that are addressed in a given science approach document or rapid screening document with the CMP3 groupings. | This information is in the list of substances in the third phase of CMP (2016-2020) rolling work plan on the CMP webpages. The Excel document found on this webpage identifies the assessment to reference when identifying assessment outcomes. Each substance is listed with its proposed CMP3 group, along with the anticipated publication quarter or year, and the assessment type. Those identified by a Type 2 assessment were analysed through a streamlined assessment method such as a science approach or rapid screening approach. |